Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 791,382 |
|
|||||
| News | - | ||||||
| Day High | 3.9199 | Low High |
|||||
| Day Low | 3.71 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Humacyte Inc | HUMA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.09 | 2.36% | 3.91 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.79 | 3.71 | 3.9199 | 3.90 | 3.82 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,681 | 791,382 | $ 3.81 | $ 3,014,710 | - | 1.96 - 5.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:28 | 75 | $ 3.87 | USD |
Humacyte Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.14B | 103.58M | - | 0 | -110.78M | -1.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Humacyte News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HUMA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.18 | 4.185 | 3.17 | 3.70 | 3,382,744 | 0.73 | 22.96% |
| 1 Month | 3.10 | 4.185 | 2.81 | 3.38 | 1,708,631 | 0.81 | 26.13% |
| 3 Months | 3.40 | 4.858 | 2.81 | 3.49 | 1,394,801 | 0.51 | 15.00% |
| 6 Months | 2.25 | 4.858 | 1.96 | 3.25 | 886,991 | 1.66 | 73.78% |
| 1 Year | 3.36 | 5.60 | 1.96 | 3.32 | 725,754 | 0.55 | 16.37% |
| 3 Years | 10.00 | 17.45 | 1.96 | 4.55 | 520,370 | -6.09 | -60.90% |
| 5 Years | 10.00 | 17.45 | 1.96 | 4.55 | 520,370 | -6.09 | -60.90% |
Humacyte Description
| Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. |
